Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
clinical trials
life sciences
national blog main
national top stories
new york top stories
3
×
san francisco top stories
biotech
boston blog main
boston top stories
europe top stories
fda
national
new york blog main
san francisco blog main
amgen
arena pharmaceuticals
billy dunn
biogen
boulder/denver blog main
boulder/denver top stories
cancer
cardiovascular disease
cholesterol
colorectal cancer
data
detroit blog main
detroit top stories
drug prices
drug pricing
eisai
europe blog main
evrysdi
gene therapy
genentech
inclisiran
indiana blog main
indiana top stories
ionis pharmaceuticals
ldl
lorcaserin
What
drug
3
×
medicine
3
×
fda
patients
aces
announced
approved
atrophy
big
cancer
ceo
cholesterol
daily
eisai
evrysdi
flags
flexible
friday
green
higher
home
incidence
inclisiran
intended
key
lights
liquid
lorcaserin
loss
lowering
market
marketing
meant
medco
medicines
muscular
nasdaq
new
open
oral
Language
unset
3
×
Current search:
drug
×
unset
×
" new york top stories "
×
medicine
×
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing